Projecting the incidence and costs of major cardiovascular and kidney complications of type 2 diabetes with widespread SGLT2i and GLP-1 RA use: a cost-effectiveness analysis
出版年份 2022 全文链接
标题
Projecting the incidence and costs of major cardiovascular and kidney complications of type 2 diabetes with widespread SGLT2i and GLP-1 RA use: a cost-effectiveness analysis
作者
关键词
-
出版物
DIABETOLOGIA
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-11-21
DOI
10.1007/s00125-022-05832-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Trends in the Incidence of Hospitalization for Major Diabetes-Related Complications in People With Type 1 and Type 2 Diabetes in Australia, 2010–2019
- (2022) Jedidiah I. Morton et al. DIABETES CARE
- Treatment gaps, 1-year readmission and mortality following myocardial infarction by diabetes status, sex and socioeconomic disadvantage
- (2022) Jedidiah I Morton et al. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH
- One-year readmission and mortality following ischaemic stroke by diabetes status, sex, and socioeconomic disadvantage: An analysis of 27,802 strokes from 2012 to 2017
- (2022) Jedidiah I. Morton et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Persistent disparities in diabetes medication receipt by socio‐economic disadvantage in Australia
- (2022) Jedidiah I. Morton et al. DIABETIC MEDICINE
- Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials
- (2021) Suetonia C Palmer et al. BMJ-British Medical Journal
- Cardiovascular disease subtypes, physical disability and workforce participation: A cross-sectional study of 163,562 middle-aged Australians
- (2021) Muhammad Shahdaat Bin Sayeed et al. PLoS One
- Comparative Efficacy of Five SGLT2i on Cardiorenal Events: A Network Meta-analysis Based on Ten CVOTs
- (2021) Mei Qiu et al. American Journal of Cardiovascular Drugs
- Do remote dialysis services really cost more? An economic analysis of hospital and dialysis modality costs associated with dialysis services in urban, rural and remote settings
- (2021) Gillian Gorham et al. BMC HEALTH SERVICES RESEARCH
- Projecting the Incidence of Type 2 Diabetes–Related End-Stage Kidney Disease Until 2040: A Comparison Between the Effects of Diabetes Prevention and the Effects of Diabetes Treatment
- (2021) Jedidiah I. Morton et al. DIABETES CARE
- Cost-Effectiveness of Empagliflozin and Metformin Combination Versus Standard Care as First-Line Therapy in Patients with Type 2 Diabetes Mellitus
- (2021) Dina Abushanab et al. Endocrine Practice
- Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes
- (2021) Hertzel C. Gerstein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trends in Diabetes Treatment and Control in U.S. Adults, 1999–2018
- (2021) Michael Fang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Employment of patients with kidney failure treated with dialysis or kidney transplantation—a systematic review and meta-analysis
- (2021) Lilli Kirkeskov et al. BMC Nephrology
- Patient, family and productivity costs of end-stage renal disease in the Netherlands; exposing non-healthcare related costs
- (2021) Eline F. de Vries et al. BMC Nephrology
- Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
- (2021) Naveed Sattar et al. Lancet Diabetes & Endocrinology
- Assessing the cost‐effectiveness of SGLT2i in type 2 diabetes mellitus: a comprehensive economic evaluation using clinical trial and real‐world evidence
- (2020) Phil McEwan et al. DIABETES OBESITY & METABOLISM
- Cost-effectiveness of dapagliflozin in chronic heart failure: an analysis from the Australian healthcare perspective
- (2020) Feby Savira et al. European Journal of Preventive Cardiology
- The High Cost of Diabetes Drugs: Disparate Impact on the Most Vulnerable Patients
- (2020) Simeon I. Taylor DIABETES CARE
- Dapagliflozin in Patients with Chronic Kidney Disease
- (2020) Hiddo J.L. Heerspink et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes
- (2020) Darren K. McGuire et al. JAMA Cardiology
- Cost Effectiveness of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, and Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: A Systematic Review
- (2019) Dongzhe Hong et al. PHARMACOECONOMICS
- Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Co-Transporter 2 Inhibitors for Prevention of MajorAdverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Cardiovascular Outcomes Trials
- (2019) Thomas A. Zelniker et al. CIRCULATION
- Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
- (2019) Hertzel C Gerstein et al. LANCET
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trends in incidence of total or type 2 diabetes: systematic review
- (2019) Dianna J Magliano et al. BMJ-British Medical Journal
- SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis
- (2019) Brendon L Neuen et al. Lancet Diabetes & Endocrinology
- Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study
- (2019) Hiddo J L Heerspink et al. Lancet Diabetes & Endocrinology
- Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs
- (2018) Mikhail Kosiborod et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2019
- (2018) DIABETES CARE
- SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- (2018) Thomas A Zelniker et al. LANCET
- Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System
- (2017) Laura Catherine Edney et al. PHARMACOECONOMICS
- Health-related quality of life measured using the EQ-5D–5L: South Australian population norms
- (2016) Nikki McCaffrey et al. Health and Quality of Life Outcomes
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Review of Utility Values for Economic Modeling in Type 2 Diabetes
- (2014) Amélie Beaudet et al. VALUE IN HEALTH
- Impact of Cardiovascular Events on Change in Quality of Life and Utilities in Patients After Myocardial Infarction
- (2014) Eldrin F. Lewis et al. JACC-Heart Failure
- Economic Costs of Diabetes in the U.S. in 2012
- (2013) DIABETES CARE
- The cost of diabetes in adults in Australia
- (2013) Crystal Man Ying Lee et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Resumption of Work After Acute Coronary Syndrome or Coronary Artery Bypass Graft Surgery
- (2013) Marian U. Worcester et al. Heart Lung and Circulation
- Employment of Patients Receiving Maintenance Dialysis and After Kidney Transplant: A Cross-sectional Study From Finland
- (2012) Ilkka Helanterä et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Trajectories of Kidney Function Decline in the 2 Years Before Initiation of Long-term Dialysis
- (2012) Ann M. O'Hare et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- The value of productivity: human-capital versus friction-cost method
- (2009) W B van den Hout ANNALS OF THE RHEUMATIC DISEASES
- Chronic diseases and labour force participation in Australia
- (2008) Xiaohui Zhang et al. JOURNAL OF HEALTH ECONOMICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now